Search Results

Return to List
Results 1–6 of 6
Sort By: Relevance | Date | Title
1.

Aromatase Inhibitors in Gynecologic Practice

Committee Opinion Number 663, June 2016

(Replaces Committee Opinion Number 412, August 2008)

ABSTRACT Aromatase inhibitors have been used for the treatment of breast cancer ovulation induction endometriosis and other estrogenmodulated conditions For women with breast cancer bone mineral density screening is recommended with longterm aromatase inhibitor use because of risk of osteoporosis ...

June 2016

PDF Format
2.

The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer

Committee Opinion Number 659, March 2016

ABSTRACT Cancer treatment should address femalespecific survivorship issues including the hypoestrogenicrelated adverse effects of cancer therapies or of natural menopause in survivors Systemic and vaginal estrogen are widely used for symptomatic relief of vasomotor symptoms sexual dysfunction and...

March 2016

PDF Format
3.

Management of Women With Dense Breasts Diagnosed by Mammography

Committee Opinion Number 625, March 2015

ABSTRACT Women with dense breasts have a modestly increased risk of breast cancer and experience reduced sensitivity of mammography to detect breast cancer However evidence is lacking to advocate for additional testing until there are clinically validated data that indicate improved screening outc...

March 2015

PDF Format
4.

Gynecologic Concerns in Children and Adolescents With Cancer

Committee Opinion Number 607, August 2014

ABSTRACT Advancements in radiation therapy chemotherapy surgery and multimodal treatment have dramatically improved childhood cancer survival However cancer and its treatment may have immediate or delayed adverse effects on reproductive health Gynecologists should be prepared to manage gynecologic...

August 2014

PDF Format
5.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Committee Opinion Number 606, August 2014

(Reaffirmed 2016)

ABSTRACT Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding and gynecologists may be consulted either before the initiation of cancer treatment to request strategies for menstrual suppression or during an episode of severe heavy bleeding to stop the bleeding emerg...

August 2014

PDF Format
6.

Induced Abortion and Breast Cancer Risk

Committee Opinion Number 434, June 2009

(Reaffirmed 2015, Replaces No. 285, August 2003)

Abstract The relationship between induced abortion and the subsequent development of breast cancer has been the subject of a substantial amount of epidemiologic study Early studies of the relationship between prior induced abortion and breast cancer risk were methodologically flawed More rigorous ...

June 2009

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998